We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microfluidic Cassette Analyses Genes and Proteins

By LabMedica International staff writers
Posted on 14 Sep 2010
A device that quickly identifies genes and proteins in body fluids has been developed that could make a vital difference to the trauma patients doctors treat. More...


A new method to isolate cells from patient samples is under development and analyzing them will help predict outcomes after severe trauma The technology, called a microfluidic cassette, allows precise analysis of very small volumes of fluids and can be used to study patients' genes and proteins.

Knowing the genomic signature of a cell population can help doctors diagnose diseases and may allow them to predict how individual patients will respond to trauma and what treatments to order. The approach also could be used with patients who have cancer or other conditions. Scientists at the University of Florida, (UF; Gainesville, FL, USA), developed and tested the cassette to isolate neutrophils, the first type of white blood cell on the scene of an infection, and to analyze the proteins they produce. A sample of fluid, such as blood or urine, is pumped through the device, which is laced with antibodies that capture the individual cells.

Testing showed the device yielded pure samples of neutrophils, and their gene expression pattern was consistent with results from tests performed in previous studies. The team was able to identify 63 genes that are differentially expressed. The genes in question regulate functions of the immune system. Patients, whose expression of these genes is abnormal, are less likely to return to their normal immune function within days of trauma, as most patients do. This leaves them more vulnerable to infections and a myriad of related complications.

Lyle L. Moldawer, Ph.D., a professor at UF said, "What is so powerful about this technique is that you can isolate any cell population quickly and efficiently at the bedside. In this case we isolated blood neutrophils, but we' have also isolated T cells, mixed leukocytes, monocytes. Theoretically, you can isolate any cell population, under any disease, and rapidly get nucleic acids to produce a genomic signature."

Kenneth Kotz, Ph.D., a research fellow at Massachusetts General Hospital (Boston, MA, USA) added, "We are getting 100 ng of ribonucleic acid (RNA) from 0.15 mL of blood and we're doing it all in 30 minutes. No one has really ever been able to do this for neutrophils. No one has been able to demonstrate the speed and the sample quality with these small blood volumes." The results of the study were published September 2010 in Nature Medicine.

Related Links:
University of Florida
Massachusetts General Hospital



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.